Skip to main content
. 2013 Feb 6;8(2):e55508. doi: 10.1371/journal.pone.0055508

Table 2. Treatment on admission and at discharge of the study cohort stratified according to gender (n = 7930).

Men(n = 6244) Women(n = 1686) P-value
Admission medical treatment
Aspirin 6145 (98.4) 1656 (98.2) 0.588
Clopidogrel 4947 (79.2) 1094 (64.9) <0.001
BB 4705 (75.4) 1190(70.6) <0.001
CCB 390 (6.2) 186 (11.0) <0.001
ACE 4420 (70.8) 1184 (70.2) 0.651
AIIRB 262 (4.2) 132 (7.8) <0.001
Statins 5936 (95.1) 1578 (93.6) 0.019
Insulin 1707 (27.3) 641 (38.0) <0.001
OHA 406 (6.5) 179 (10.6) <0.001
In-hospital invasive procedures
Cardiac angiography 2120 (34.0) 456 (27.0) <0.001
PCI 971 (15.6) 177 (10.5) <0.001
CABG 193 (3.1) 40 (2.4) 0.125
Reperfusion therapy 1259 (20.2) 117 (6.9) <0.001
Discharge medical treatment
Aspirin 5834 (93.5) 1523 (90.4) <0.001
Clopidogrel 4439(71.1) 924 (54.8) <0.001
BB 5020 (80.6) 1248 (74.3) <0.001
CCB 415 (6.7) 203 (12.1) <0.001
ACE 4501 (72.3) 1140 (67.9) <0.001
AIIRB 369 (5.9) 167 (9.9) <0.001
Statins 5735 (92.1) 1482 (88.2) <0.001
Insulin 747 (12.0) 374 (22.3) <0.001
OHA 1486 (23.9) 513 (30.5) <0.001

Figures in parentheses are percentages. Abbreviations: BB, beta-blockers; CCB, calcium channel blockers; ACE, angiotensin-converting enzyme inhibitors; AIIRB, angiotensin II receptor blockers; OHA, oral hypoglycemic agents; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft.